Piramal Pharma Limited Net Asset Momentum
Piramal Pharma Limited net asset momentum. Piramal Pharma Limited (PPLPHARMA) recorded a net asset momentum of 0.5% as of March 2026, with net assets of Rs81.63 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Piramal Pharma Limited for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Piramal Pharma Limited (2021–2026)
Net asset momentum of Piramal Pharma Limited from 2021 to 2026. This chart tracks Piramal Pharma Limited's year-over-year net asset growth across 6 annual reporting periods from 2021 to 2026. The most recent momentum reading is +0.5%, with net assets of Rs81.63 Billion INR as of March 2026. Check Piramal Pharma Limited tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Piramal Pharma Limited Net Asset Momentum by Year (2021–2026)
Piramal Pharma Limited net asset momentum by year from 2021 to 2026. The table below shows the complete annual net asset history for Piramal Pharma Limited from 2021 to 2026, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see PPLPHARMA market cap overview.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs81.63 Billion | Rs179.65 Billion | Rs98.02 Billion | ▲ +0.5% |
| 2025 | Rs81.25 Billion | Rs156.78 Billion | Rs75.52 Billion | ▲ +2.7% |
| 2024 | Rs79.11 Billion | Rs153.12 Billion | Rs74.00 Billion | ▲ +16.8% |
| 2023 | Rs67.73 Billion | Rs145.23 Billion | Rs77.49 Billion | ▲ +1.1% |
| 2022 | Rs66.97 Billion | Rs127.97 Billion | Rs61.00 Billion | ▲ +63.3% |
| 2021 | Rs41.01 Billion | Rs57.57 Billion | Rs16.56 Billion | — |